Reported about 14 hours ago
Ionis Pharmaceuticals' stock reached a six-year high due to positive market performance and an increase in its price target. Investors are encouraged to consider Ionis for its potential, along with accessing exclusive stock analysis and market tools.
Source: INVESTORS